Vonafexor ALPort Syndrome Efficacy & Safety TRIAl-1 (ALPESTRIA-1)
Public ClinicalTrials.gov record NCT06425055. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Vonafexor Fixed Dose-escalation Safety and Proof-of-concept Study in Patients With at Risk of Progression Alport Syndrome
Study identification
- NCT ID
- NCT06425055
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Enyo Pharma
- Industry
- Enrollment
- 26 participants
Conditions and interventions
Conditions
Interventions
- Vonafexor Drug
Drug
Eligibility (public fields only)
- Age range
- 16 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2024
- Primary completion
- Sep 3, 2025
- Completion
- Nov 19, 2025
- Last update posted
- Feb 8, 2026
2024 – 2025
United States locations
- U.S. sites
- 7
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dr Eric Wallace - University of Alabama | Birmingham | Alabama | 35294 | — |
| Dr Anjay Rastogi - UCLA Health, David Geffen School of Medicine | Los Angeles | California | 90095 | — |
| Dr Arnold Silva - Boise Kidney & Hypertension | Boise | Idaho | 83703 | — |
| Dr Suneel Udani - NANI Research | Hinsdale | Illinois | 60521 | — |
| Dr Tingting Li - Washington University | St Louis | Missouri | 63110 | — |
| Dr James Simon - Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Dr Ankit Mehta - Renal Disease Research Institute | Dallas | Texas | 75126 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06425055, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 8, 2026 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06425055 live on ClinicalTrials.gov.